fbpx
September 16, 2025

CDER Conversations

Discussions with key Center for Drug Evaluation and Research (CDER) leadership about important regulatory and policy issues Content current as of: 03/26/2025 Regulated Product(s)
September 16, 2025

Drug Trials Snapshots: ANDEMBRY

HOW TO USE THIS SNAPSHOT The information provided in Snapshots highlights who participated in the key clinical trials that supported the original FDA approval of this drug, […]
September 16, 2025

Novo Nordisk Inc. – 716495 – 09/09/2025

Product: Drugs Recipient: Recipient Name Maziar Mike Doustdar Recipient Title President and Chief Executive Officer Novo Nordisk Inc. 800 Scudders Mill RoadPlainsboro, NJ 08536United States Issuing […]
September 16, 2025

FWD Care, Inc. dba FWD – 716696 – 09/09/2025

Delivery Method: VIA ELECTRONIC MAIL READ/DELIVERY RECEIPT REQUESTED Product: Drugs Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary Issuing Offices United States […]
September 16, 2025

Aytu Biopharma – 716599 – 09/09/2025

Product: Drugs Recipient: Recipient Name Josh Disbrow Recipient Title Chief Executive Officer Aytu Biopharma 7900 E. Union Avenue, Suite 920Denver, CO 80237United States Issuing Office: Center […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0